Literature DB >> 19200758

Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.

Susan Johnson1, Yifan Zhan, Robyn M Sutherland, Adele M Mount, Sammy Bedoui, Jamie L Brady, Emma M Carrington, Lorena E Brown, Gabrielle T Belz, William R Heath, Andrew M Lew.   

Abstract

CD40L (CD154) on CD4(+) T cells has been shown to license dendritic cells (DCs) via CD40 to prime cytotoxic T lymphocyte (CTL) responses. We found that the converse (CD40L on DCs) was also important. Anti-CD40L treatment decreased endogenous CTL responses to both ovalbumin and influenza infection even in the absence of CD4(+) T cells. DCs expressed CD40L upon stimulation with agonists to Toll-like receptor 3 (TLR3) and TLR9. Moreover, influenza infection, which stimulates CTLs without help, upregulated CD40L on DCs, but herpes simplex infection, which elicits CTLs through help, did not. CD40L-deficient (Cd40lg(-/-)) DCs are suboptimal both in vivo in bone marrow chimera experiments and in vitro in mixed lymphocyte reactions. In contrast, Cd40lg(-/-) CD8(+) T cells killed as effectively as wild-type cells. Thus, CD40L upregulation on DCs promoted optimal priming of CD8(+) T cells without CD4(+) T cells, providing a mechanism by which pathogens may elicit helper-independent CTL immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200758      PMCID: PMC2694753          DOI: 10.1016/j.immuni.2008.11.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  75 in total

1.  T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

Authors:  S P Schoenberger; R E Toes; E I van der Voort; R Offringa; C J Melief
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

Review 2.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

3.  Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.

Authors:  L A Trimble; P Shankar; M Patterson; J P Daily; J Lieberman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Functional CD40 ligand is expressed on epidermal Langerhans cells.

Authors:  C G Salgado; K Nakamura; M Sugaya; Y Tada; A Asahina; Y Koyama; S Irie; K Tamaki
Journal:  J Leukoc Biol       Date:  1999-08       Impact factor: 4.962

5.  Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.

Authors:  S O Andreasen; J E Christensen; O Marker; A R Thomsen
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

6.  The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses.

Authors:  M A Ostrowski; S J Justement; L Ehler; S B Mizell; S Lui; J Mican; B D Walker; E K Thomas; R Seder; A S Fauci
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

7.  Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.

Authors:  A D Kirk; L C Burkly; D S Batty; R E Baumgartner; J D Berning; K Buchanan; J H Fechner; R L Germond; R L Kampen; N B Patterson; S J Swanson; D K Tadaki; C N TenHoor; L White; S J Knechtle; D M Harlan
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

8.  CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.

Authors:  Y Zhan; A J Corbett; J L Brady; R M Sutherland; A M Lew
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

9.  Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.

Authors:  M Saurwein-Teissl; K Zisterer; T L Schmitt; R Glück; S Cryz; B Grubeck-Loebenstein
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo.

Authors:  C Ruedl; M Kopf; M F Bachmann
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more
  44 in total

Review 1.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 3.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

4.  A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses.

Authors:  Liang Xiao; Jocelyn Kim; Matthew Lim; Bingbing Dai; Lili Yang; Steven G Reed; David Baltimore; Pin Wang
Journal:  Vaccine       Date:  2012-02-05       Impact factor: 3.641

5.  CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.

Authors:  Lauren E Yauch; Tyler R Prestwood; Monica M May; Malika M Morar; Raphaël M Zellweger; Bjoern Peters; Alessandro Sette; Sujan Shresta
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

6.  LTβR signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8+ T cells.

Authors:  Leslie Summers deLuca; Dennis Ng; Yunfei Gao; Michael E Wortzman; Tania H Watts; Jennifer L Gommerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

7.  Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.

Authors:  Nicholas M Provine; Rafael A Larocca; Pablo Penaloza-MacMaster; Erica N Borducchi; Anna McNally; Lily R Parenteau; David R Kaufman; Dan H Barouch
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

Review 8.  Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.

Authors:  David F Pinelli; Mandy L Ford
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

Review 9.  Memories that last forever: strategies for optimizing vaccine T-cell memory.

Authors:  Jeffrey D Ahlers; Igor M Belyakov
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

Review 10.  T Cell Cosignaling Molecules in Transplantation.

Authors:  Mandy L Ford
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.